US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
アメリカ
USOTC
Nemaura Medical Inc (EM) (NMRD) 銘柄情報

Nemaura Medical Inc (EM) (NMRD)

0.0001

0.00

( 0.00% )

更新日時： 09:00:00

Nemaura Medical Inc (EM) (NMRD) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.0001

( - )

買値

0.00

売値

0.00

出来高

27,305

0.0001 日の範囲 0.0001

0.000001 52 週間の範囲 0.05

時価総額

前日終値

0.0001

始値

0.0001

時刻

最終取引時間

23:32:33

財務取引量

US$ 3

VWAP

0.0001

平均取引量 (3 か月)

US$ 3,133

発行済株式数

40,351,702

配当利回り

PER

-0

1 株当たり利益 (EPS)

-0.38

歳入

-

純利益

-10.65M

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The compa... Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

nemauramedical.com

本社

New York, United States

設立

2026

Nemaura Medical Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker NMRD. The last closing price for Nemaura Medical (EM) was US$0. Over the last year, Nemaura Medical (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.05.

Nemaura Medical (EM) currently has 40,351,702 shares in issue. The market capitalisation of Nemaura Medical (EM) is US$4,035.17 . Nemaura Medical (EM) has a price to earnings ratio (PE ratio) of -0.00.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	9.9E-5	9900	1.0E-6	0.0002	1.0E-6	6835	9.981E-5	CS
4	-0.0001	-50	0.0002	0.0002	1.0E-6	4232	0.00013931	CS
12	-0.0001	-50	0.0002	0.0005	1.0E-6	3253	0.00015464	CS
26	0	0	0.0001	0.0005	1.0E-6	4336	0.00011606	CS
52	0	0	0.0001	0.05	1.0E-6	5838	0.00017012	CS
156	-0.0711	-99.8595505618	0.0712	0.128	1.0E-6	21176	0.05565387	CS
260	-5.6499	-99.9982300885	5.65	5.65	1.0E-6	20885	0.05565387	CS

NMRD - Frequently Asked Questions (FAQ)

What is the current Nemaura Medical Inc (EM) share price?

The current share price of Nemaura Medical Inc (EM) is US$ 0.0001

How many Nemaura Medical Inc (EM) shares are in issue?

Nemaura Medical Inc (EM) has 40,351,702 shares in issue

What is the market cap of Nemaura Medical Inc (EM)?

The market capitalisation of Nemaura Medical Inc (EM) is USD 4.04k

What is the 1 year trading range for Nemaura Medical Inc (EM) share price?

Nemaura Medical Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.05 during the past year

What is the PE ratio of Nemaura Medical Inc (EM)?

The price to earnings ratio of Nemaura Medical Inc (EM) is -0

What is the registered address of Nemaura Medical Inc (EM)?

The registered address for Nemaura Medical Inc (EM) is 57 West 57th Street, New York, New York, 10019

What is the Nemaura Medical Inc (EM) website address?

The website address for Nemaura Medical Inc (EM) is nemauramedical.com

Which industry sector does Nemaura Medical Inc (EM) operate in?

Nemaura Medical Inc (EM) operates in the Medical Equipment & Supplies sector

glenn1919

glenn1919 6分前

ATLN......................https://stockcharts.com/sc3/ui/?s=ATLN&p=d&yr=0&mn=2&dy=12&id=p84071410134

ghostandgurgi

ghostandgurgi 7分前

It is good to see that they intend on appealing the scope of the receivership as well as the fees associated with it. Honestly, the scope is the biggest issue. If the appellate court rules that it was too broad, and/ or that once the monies were tendered the receivership should have terminated th

Truthsocial

Truthsocial 7分前

Elaborating on the regulatory pathway, an Early Feasibility Study (EFS) Investigational Device Exemption (IDE) approval and corresponding Institutional Review Board (IRB) approval are strictly limited to the specific investigational plan submitted and reviewed. They do not serve as a blanket authori

vlispxpert

vlispxpert 7分前

FDMT biggest winner of sympathy trades...so far ;)

Chartmaster

Chartmaster 7分前

This time we break below 60k for good imo

i_like_bb_stock

i_like_bb_stock 8分前

$CPOP took some here looking like it wants to run, pennies are hot

investingnotgambling

investingnotgambling 8分前

OTCN dumped a ton of shares this morning. Big bids showing now. Big run coming? 🤔

i_like_bb_stock

i_like_bb_stock 8分前

$CPOP took some here looking like it wants to run, pennies are hot

firejourneyman

firejourneyman 8分前

personally, I think Nokia will be revealed as one of the tier 1 customers currently in stage 3. potentially the 1.6T transceiver at 200G/lane (see march earnings call for customer details)

- long history with Nokia Bell Labs + Polariton + LWLG
- Dr. Chowdhury came from Nokia

Fallingknife75

Fallingknife75 8分前

Excellent article, thanks for posting it :)

All the best,

Knife

ALERTS100%to10000%GAIN

ALERTS100%to10000%GAIN 9分前

ADTX~~.0452, could hit today .06+++ after hours

twotickets

twotickets 9分前

NUGL nice volume.

tryn2

Doc logic

Doc logic 10分前

brazen22,

Your thinking blows right past the fact that approval alone brings an immediate uptick in initial demand. Yes, there are ways to control demand for a while but this is an artificial control measure utilized to stymie true initial demand for what would be expected to be a re

splintered sunlight

splintered sunlight 10分前

I sold a little - going to wait on the rest.

U?

LessIsMore

LessIsMore 10分前

You should read the board more

I'm sorry but I don't spend my entire day on this board, I don't have a desire to be the most prolific poster. I have a life.

I-Glow

I-Glow 11分前

Musk only allocated 5% of the stock to the public and he owns 42% of the stock.

So the stock is closely held with a small float making it easy to manipulate the price.

IG

easymonee

easymonee 12分前

So true.

GLTAL

US Market News

US Market News 12分前

AVAV Class Action Lawsuit: AeroVironment Sued for Securities Fraud after SCAR Contract Cancellation Leads to 17% Stock Drop – Investors Notified to Contact BFA LawJune 23, 2026 1:17 PM
Business WireA securities fraud class action lawsuit has been filed on behalf of AeroVironmen

Chartmaster

Chartmaster 12分前

I have Windows classic shell program on my 2 computers so it looks like windows 7 and XP, never understood why they have to keep changing things when all we do is just the same things on our computers everyday

CA Market News

CA Market News 12分前

Fox River Obtains Securityholder Approval for Plan of Arrangement with Avenir Minerals LimitedJune 23, 2026 1:15 PM
ACCESS NewswireTORONTO, ON / ACCESS Newswire / June 23, 2026 / Fox Riv

US Market News

US Market News 12分前

Group 1 Automotive Continues Nationwide Brand Alignment with Group 1 Hyundai Southwest Houston in southwest HoustonJune 23, 2026 1:24 PM
PR Newswire (US) Former Sterling McCall Hyundai location is among the dealerships now operating under the unified Gr

US Market News

US Market News 13分前

Paul Davis Joins Eastern Bank As Senior Vice President, Commercial Real Estate Relationship ManagerJune 23, 2026 1:30 PM
Business Wire Mr. Davis Brings More Than 25 Years of Experience In Commercial Real Estate Lending

OracleWitch66

OracleWitch66 13分前

No dumping is good but we need news imo

Golden Cross

Golden Cross 14分前

$AABB Market Valuation of AABB Gold and Silver Holdings Nears $90M As Precious Metal Strategy Gathers Momentum
https://www.globenewswire.com/news-release/2026/06/03/3305985/0/en/Market-Valuation-of-AABB-Gold-and-Silver-Holdings-Nears-90M-As-Precious-Metal-Strategy-Gathers-Momentum.html

Nemaura Medical (EM)

AXA Bank Europe SCF

6% sNR uNSEC nOTES 11/12...

Konecranes (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。